Johnson & Johnson has received FDA approval for a dual-energy ablation catheter, which reportedly addresses a key limitation of pulmonary vein ablation. The approved system is intended for use in cardiac ablation procedures. It is unclear how this development will impact the competitive landscape, as other companies, such as Abbott, are also making advancements in the field of ablation catheters.